To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Advanced Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)
- Status
- RECRUITING
- Phase
- PHASE3
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT
- Status
- WITHDRAWN
- Phase
- NA
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients
- Status
- COMPLETED
- Phase
- PHASE2
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- Status
- RECRUITING
- Phase
- PHASE1
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2